F 0553
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Allow resident to participate in the development and implementation of his or her person-centered plan of
care.
Based on interview and record review, the facility failed to protect the right of one of three sampled
residents (Resident 1) to participate in the resident's treatment when the facility failed to give Resident 1's
Pramipexole Dihydrochloride (medication used to treat Parkinson's disease [a brain disorder that causes
unintended or uncontrollable movements, such as shaking, stiffness, and difficulty with balance and
coordination]) at Resident 1's requested time.
This failure had the potential for Resident 1 to experience an increase in tremors (involuntary, rhythmic
shaking movements that can affect various parts of the body).
Findings:
During a review of Resident 1's admission Record (AR), the AR indicated the facility admitted Resident 1
on 1/20/2025, with diagnoses including Parkinson's disease, chronic obstructive pulmonary disease
(COPD, a group of diseases that cause airflow blockage and breathing-related problems), and need for
assistance with personal care.
During a review of Resident 1's physician order (PO) dated 1/20/2025, the PO indicated an order for
Pramipexole Dihydrochloride oral tablet one (1) milligrams (mg, unit of measurement), give 1 tablet by
mouth three times a day for Parkinson's disease.
During a review of Resident 1's History and Physical Examination (H&P), dated 1/21/2025, the H&P
indicated Resident 1 had the capacity to understand and make decisions.
During an interview on 1/28/2025 at 11:05 a.m. with Resident 1, Resident 1 stated her Parkinson's
medication (Pramipexole Dihydrochloride) was being given to Resident 1 daily at 9 a.m. Resident 1 stated
Resident 1 wanted the medication to be given to her at 7:30 a.m. because the medication being given at
that time helped Resident 1 to not shake from her Parkinson's disease. Resident 1 stated Resident 1 spoke
to facility staff (unidentified) about changing the medication time from 9 a.m. to 7:30 a.m. but facility staff
continued to give Resident 1 the medication at 9 a.m. Resident 1 stated the medication administration time
was finally changed to 7:30 a.m. as Resident 1 requested on 1/27/2025.
During a concurrent interview and record review on 1/29/2025 at 10:15 a.m. with the Assistant Director of
Nursing (ADON), Resident 1's Medication Administration Record (MAR), dated January 2025 and Resident
2's IDT (Interdisciplinary Team, a group of health care professionals with various areas of expertise who
work together toward the goals of the resident) Care Conference Notes (IDT Notes), dated 1/21/2025 were
reviewed. The IDT Notes indicated on 1/21/2025, the IDT met with Resident 1
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 4
Event ID:
555416
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555416
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
01/29/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Glendora Canyon Transitional Care Unit
401 W. Ada Ave.
Glendora, CA 91741
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0553
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
regarding Resident 1's care and goals while at the facility. The ADON stated the ADON was present at the
IDT meeting. The ADON stated Resident 1 requested the facility to administer Resident 1's Pramipexole
Dihydrochloride medication to Resident 1 before breakfast at around 6 a.m. to 7 a.m. The ADON stated
Resident 1 informed the ADON that Resident 1 would experience tremors when she did not receive the
medication before breakfast. The MAR indicated Resident 1 received the morning dose of Pramipexole
Dihydrochloride at 9 a.m. from 1/21/2025 to 1/23/2025. The ADON confirmed she was aware of Resident
1's request to change the medication time on the evening of 1/21/2025, and that the medication time was
not changed for Resident 1 until 1/24/2025. The ADON stated facility staff should have accommodated
Resident 1's request to change the medication administration time of Resident 1's Pramipexole
Dihydrochloride from 9 a.m. to 7:30 a.m. on 1/22/2025.
During a review of the facility's policy and procedure (P&P) titled, Resident Rights, revised December 2019,
the P&P indicated, . Federal and state laws guarantee certain basic rights to all residents of this facility.
These rights include the resident's right to .be informed of, and participate in, his or her care planning and
treatment .choose an attending physician and participate in decision -making regarding his or her care .
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555416
If continuation sheet
Page 2 of 4
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555416
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
01/29/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Glendora Canyon Transitional Care Unit
401 W. Ada Ave.
Glendora, CA 91741
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0761
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Ensure drugs and biologicals used in the facility are labeled in accordance with currently accepted
professional principles; and all drugs and biologicals must be stored in locked compartments, separately
locked, compartments for controlled drugs.
Based on observation, interview, and record review, the facility failed to ensure medications for one of three
sampled residents (Resident 2) were kept locked in secure storage when Resident 2's morning medications
were observed to be unattended at Resident 2's bedside.
This failure had the potential for Resident 2 to not receive Resident 2's scheduled medications and had the
potential to cause harm to other residents who could access and swallow the unattended medications.
Findings:
During a review of Resident 2's admission Record (AR), the AR indicated the facility admitted Resident 2
on 10/29/2024, with diagnoses including metabolic encephalopathy (brain disease that alters brain function
or structure), transient cerebral ischemic attack (a temporary interruption of blood flow to the brain), and
dementia (a group of thinking and social symptoms that interferes with daily functioning).
During a review of Resident 2's Minimum Data Set (MDS, a resident assessment tool), dated 11/2/2024,
the MDS indicated Resident 2 was severely impaired (never/rarely made decisions) in cognitive skills. The
MDS indicated Resident 2 required partial/moderate assistance (helper does less than half the effort) from
staff for oral, toileting, and personal hygiene and dressing.
During a concurrent observation and interview on 1/28/2025 at 11:46 a.m. with Resident 2, in Resident 2's
room, a medication cup containing three pills (unidentified) was observed on the dresser next to Resident
2's bed. Resident 2 stated Resident 2 did not know how long the cup of medicine had been sitting on the
dresser.
During a concurrent observation and interview on 1/28/2025 at 11:47 a.m. with Licensed Vocational Nurse
(LVN) 1, LVN 1 confirmed there was a medication cup containing three (unidentified) medications at
Resident 2's bedside, unattended. LVN 1 stated LVN 2 was the nurse responsible to give medications to
Resident 2 and that LVN 2 was currently on a lunch break. LVN 1 stated the unattended medications were
unsafe because another resident (in general) could have taken/swallowed the medications. LVN 1 removed
the medications from the Resident 2's room.
During a concurrent observation and interview on 1/28/2025 at 12:13 p.m. with LVN 2, LVN 2 had the cup of
three medications at LVN 2's medication cart. LVN 2 confirmed the three medications were from the
morning med pass (on 1/28/2025). LVN 2 stated LVN 2 should have remained at Resident 2's bedside after
LVN 2 gave Resident 2 her (Resident 2's) medications. LVN 2 stated LVN 2 needed to ensure Resident 2
had swallowed the medications before leaving Resident 2's room.
During an interview on 1/28/2025 at 1:58 p.m. with the Director of Nursing (DON), the DON stated LVN 2
had left medication at another resident's (unidentified) bedside previously. The DON stated nursing staff (in
general) are required to stay by the resident (in general) during medication pass and ensure residents (in
general) have swallowed the residents' medication/s. The DON stated nursing staff (in general) were not
permitted to leave residents' (in general) medications at the bedside.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555416
If continuation sheet
Page 3 of 4
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555416
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
01/29/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Glendora Canyon Transitional Care Unit
401 W. Ada Ave.
Glendora, CA 91741
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0761
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
During a review of the facility's policy and procedure (P&P) titled, Administering Medications, revised
December 2019, the P&P indicated, Medications shall be administered in a safe and timely manner, and as
prescribed.
During a review of the facility's P&P titled, Storage of Medications, revised November 2020, the P&P
indicated, The facility stores all drugs and biologicals in a safe, secure, and orderly manner. The P&P
indicated:
1. Drugs and biologicals used in the facility are stored in locked compartments under proper temperature,
light and humidity controls. Only persons authorized to prepare and administer medications have access to
locked medications.
2. Drugs and biologicals are stored in the packaging, containers or other dispensing systems in which they
are received. Only the issuing pharmacy is authorized to transfer medications between containers.
3. The nursing staff is responsible for maintaining medication storage and preparation areas in a clean,
safe, and sanitary manner.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555416
If continuation sheet
Page 4 of 4